Redo nephron-sparing surgery in stage V pediatric renal tumors - A report from the SIOP/GPOH study group for renal tumors.

Fuchs, Jörg; Schunn, Matthias C; Schäfer, Jürgen F; Ebinger, Martin; Graf, Norbert; Furtwängler, Rhoikos; Warmann, Steven W (2024). Redo nephron-sparing surgery in stage V pediatric renal tumors - A report from the SIOP/GPOH study group for renal tumors. European journal of surgical oncology EJSO, 50(1), p. 107265. Elsevier 10.1016/j.ejso.2023.107265

[img] Text
1-s2.0-S0748798323009034-main.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (2MB)

PURPOSE

Nephron-sparing Surgery (NSS) is the surgical treatment of choice in children with bilateral renal tumors or in syndromatic patients. With an increasing role of this surgical approach, there is also an increased number of tumor relapses after NSS. Aim of this study was to evaluate a second ("Redo-") NSS in children with relapsed renal tumors.

MATERIALS AND METHODS

We retrospectively analysed patients undergoing Redo-NSS for relapsed kidney tumors between 2009 and 2021 at our institution, which represents a national reference center of the SIOP/GPOH renal tumor study group.

RESULTS

Nine patients (5 girls, 4 boys) underwent Redo-NSS with resection of 15 lesions. Mean age at surgery was 58 months (12-137), mean operative time for Redo-NSS was 195 min (137-260). R0 resection status was achieved in all children. Two patients had second relapses, one of them was resected via NSS, the other child underwent tumor nephrectomy. Two patients with anaplastic relapses died from combined second relapses. Thus, 7/9 patients are alive without evidence of disease, an impaired renal function was observed in one child. Mean follow-up after Redo-NSS was 35 months (6-49).

CONCLUSIONS

In renal tumor relapses, Redo-NSS can be performed with satisfactory oncological and functional results. Occurrence of diffuse anaplasia should possibly refrain from this approach. Further evaluation in international multicenter analyses are necessary for a definitive determination of Redo-NSS.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine
04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine > Paediatric Haematology/Oncology

UniBE Contributor:

Furtwängler, Rhoikos

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1532-2157

Publisher:

Elsevier

Language:

English

Submitter:

Anette van Dorland

Date Deposited:

25 Jan 2024 07:07

Last Modified:

25 Jan 2024 07:07

Publisher DOI:

10.1016/j.ejso.2023.107265

PubMed ID:

38035461

Uncontrolled Keywords:

Nephroblastoma Nephron-sparing surgery Tumor relapse

BORIS DOI:

10.48350/192107

URI:

https://boris.unibe.ch/id/eprint/192107

Actions (login required)

Edit item Edit item
Provide Feedback